Biotest Aktiengesellschaft (ETR:BIO - Get Free Report)'s stock price traded up 0.9% during mid-day trading on Thursday . The company traded as high as €42.80 ($48.64) and last traded at €42.80 ($48.64). 79 shares changed hands during mid-day trading, a decline of 96% from the average session volume of 1,927 shares. The stock had previously closed at €42.40 ($48.18).
Biotest Aktiengesellschaft Stock Down 0.5%
The company has a market capitalization of $843.05 million, a P/E ratio of 10.27 and a beta of 0.24. The firm has a fifty day simple moving average of €42.53 and a 200-day simple moving average of €41.72.
About Biotest Aktiengesellschaft
(
Get Free Report)
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
See Also
Before you consider Biotest Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Biotest Aktiengesellschaft wasn't on the list.
While Biotest Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
